Mitochondrial reactive oxygen species trigger metformin-dependent antitumor immunity via activation of Nrf2/mTORC1/p62 axis in tumor-infiltrating CD8T lymphocytes
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mitochondrial reactive oxygen species trigger metformin-dependent antitumor immunity via activation of Nrf2/mTORC1/p62 axis in tumor-infiltrating CD8T lymphocytes
Authors
Keywords
-
Journal
Journal for ImmunoTherapy of Cancer
Volume 9, Issue 9, Pages e002954
Publisher
BMJ
Online
2021-09-17
DOI
10.1136/jitc-2021-002954
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Regulation of Nrf2 by Mitochondrial Reactive Oxygen Species in Physiology and Pathology
- (2020) Shuya Kasai et al. Biomolecules
- Fasting-Refeeding Impacts Immune Cell Dynamics and Mucosal Immune Responses
- (2019) Motoyoshi Nagai et al. CELL
- Oxidative phosphorylation as a potential therapeutic target for cancer therapy
- (2019) Valentina Sica et al. INTERNATIONAL JOURNAL OF CANCER
- Interferon-gamma induces autophagy-associated apoptosis through induction of cPLA2-dependent mitochondrial ROS generation in colorectal cancer cells
- (2018) Qiu-Shuang Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Metformin-Induced Reduction of CD39 and CD73 Blocks Myeloid-Derived Suppressor Cell Activity in Patients with Ovarian Cancer
- (2018) Lifeng Li et al. CANCER RESEARCH
- Oxidative Phosphorylation as an Emerging Target in Cancer Therapy
- (2018) Thomas M. Ashton et al. CLINICAL CANCER RESEARCH
- Metformin's antitumour and anti-angiogenic activities are mediated by skewing macrophage polarization
- (2018) Ji-Chang Wang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Metformin blocks myeloid-derived suppressor cell accumulation through AMPK-DACH1-CXCL1 axis
- (2018) Guohui Qin et al. OncoImmunology
- Efficacy of metformin in combination with immune checkpoint inhibitors (anti-PD-1/anti-CTLA-4) in metastatic malignant melanoma
- (2018) Muhammad Zubair Afzal et al. Journal for ImmunoTherapy of Cancer
- Metformin induces CD11b+-cell-mediated growth inhibition of an osteosarcoma: implications for metabolic reprogramming of myeloid cells and anti-tumor effects
- (2018) Takenori Uehara et al. INTERNATIONAL IMMUNOLOGY
- Physiological role of reactive oxygen species as promoters of natural defenses
- (2017) Jérôme Roy et al. FASEB JOURNAL
- Rescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependent
- (2017) Alice O. Kamphorst et al. SCIENCE
- Role of Nrf2 and protective effects of Metformin against tobacco smoke-induced cerebrovascular toxicity
- (2017) Shikha Prasad et al. Redox Biology
- Attenuation of CD4 + CD25 + Regulatory T Cells in the Tumor Microenvironment by Metformin, a Type 2 Diabetes Drug
- (2017) Yuki Kunisada et al. EBioMedicine
- Metformin is not just an antihyperglycaemic drug but also has protective effects on the vascular endothelium
- (2016) C. R. Triggle et al. Acta Physiologica
- Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
- (2016) Jianjun Gao et al. CELL
- LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells
- (2016) Almut Brand et al. Cell Metabolism
- Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism
- (2016) Agnieszka Loboda et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming
- (2016) Tetsuya Saito et al. Nature Communications
- Fatty Acid Oxidation-Driven Src Links Mitochondrial Energy Reprogramming and Oncogenic Properties in Triple-Negative Breast Cancer
- (2016) Jun Hyoung Park et al. Cell Reports
- Local Tumor Treatment in Combination with Systemic Ipilimumab Immunotherapy Prolongs Overall Survival in Patients with Advanced Malignant Melanoma
- (2016) S. Theurich et al. Cancer Immunology Research
- Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia
- (2016) Nicole E. Scharping et al. Cancer Immunology Research
- Interactions between mitochondrial reactive oxygen species and cellular glucose metabolism
- (2015) Dania C. Liemburg-Apers et al. ARCHIVES OF TOXICOLOGY
- Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses
- (2015) Ping-Chih Ho et al. CELL
- Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
- (2015) Chih-Hao Chang et al. CELL
- Deficiency of Interferon-Gamma or Its Receptor Promotes Colorectal Cancer Development
- (2015) Lu Wang et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Immune-mediated antitumor effect by type 2 diabetes drug, metformin
- (2015) Shingo Eikawa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IRF8 directs stress-induced autophagy in macrophages and promotes clearance of Listeria monocytogenes
- (2015) Monica Gupta et al. Nature Communications
- Nuclear factor erythroid 2-related factor 2 (Nrf2) regulates airway epithelial barrier integrity
- (2015) Yoshitaka Shintani et al. ALLERGOLOGY INTERNATIONAL
- PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis
- (2014) Valerie S. LeBleu et al. NATURE CELL BIOLOGY
- Metformin—mode of action and clinical implications for diabetes and cancer
- (2014) Ida Pernicova et al. Nature Reviews Endocrinology
- Metformin promotes lifespan through mitohormesis via the peroxiredoxin PRDX-2
- (2014) W. De Haes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis
- (2014) William W Wheaton et al. eLife
- Cytotoxic T Lymphocytes Block Tumor Growth Both by Lytic Activity and IFN -Dependent Cell-Cycle Arrest
- (2014) H. Matsushita et al. Cancer Immunology Research
- Mitochondria Are Required for Antigen-Specific T Cell Activation through Reactive Oxygen Species Signaling
- (2013) Laura A. Sena et al. IMMUNITY
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Deficiency of p62/Sequestosome 1 Causes Hyperphagia Due to Leptin Resistance in the Brain
- (2013) H. Harada et al. JOURNAL OF NEUROSCIENCE
- Phosphorylation of p62 Activates the Keap1-Nrf2 Pathway during Selective Autophagy
- (2013) Yoshinobu Ichimura et al. MOLECULAR CELL
- Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
- (2012) Yoichiro Mitsuishi et al. CANCER CELL
- Glutaminolysis Activates Rag-mTORC1 Signaling
- (2012) Raúl V. Durán et al. MOLECULAR CELL
- Serine 403 Phosphorylation of p62/SQSTM1 Regulates Selective Autophagic Clearance of Ubiquitinated Proteins
- (2011) Gen Matsumoto et al. MOLECULAR CELL
- Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer
- (2010) M. Bodmer et al. DIABETES CARE
- Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state
- (2010) Marc Foretz et al. JOURNAL OF CLINICAL INVESTIGATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now